BR9711134A - Composto e uso de um composto - Google Patents
Composto e uso de um compostoInfo
- Publication number
- BR9711134A BR9711134A BR9711134A BR9711134A BR9711134A BR 9711134 A BR9711134 A BR 9711134A BR 9711134 A BR9711134 A BR 9711134A BR 9711134 A BR9711134 A BR 9711134A BR 9711134 A BR9711134 A BR 9711134A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- compounds
- preparation
- description
- meanings stated
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19632772A DE19632772A1 (de) | 1996-08-14 | 1996-08-14 | Neue Benzamidine |
| DE9704105 | 1997-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9711134A true BR9711134A (pt) | 1999-08-17 |
Family
ID=7802623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9711134A BR9711134A (pt) | 1996-08-14 | 1997-07-29 | Composto e uso de um composto |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6440937B1 (pt) |
| EP (1) | EP0918792B1 (pt) |
| JP (1) | JP2000517300A (pt) |
| KR (1) | KR20000030004A (pt) |
| CN (1) | CN1233256A (pt) |
| AT (1) | ATE196637T1 (pt) |
| AU (1) | AU717692B2 (pt) |
| BR (1) | BR9711134A (pt) |
| CA (1) | CA2263344A1 (pt) |
| CZ (1) | CZ31199A3 (pt) |
| DE (2) | DE19632772A1 (pt) |
| ES (1) | ES2151741T3 (pt) |
| HU (1) | HUP0001796A3 (pt) |
| IL (1) | IL128231A0 (pt) |
| NO (1) | NO990667L (pt) |
| TW (1) | TW442471B (pt) |
| WO (1) | WO1998006740A1 (pt) |
| ZA (1) | ZA977240B (pt) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9602263D0 (sv) | 1996-06-07 | 1996-06-07 | Astra Ab | New amino acid derivatives |
| SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
| DE19632773A1 (de) * | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
| AR013084A1 (es) | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
| SE9704543D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Ab | New compounds |
| CA2334476A1 (en) | 1998-06-08 | 1999-12-16 | Ajinomoto Co., Inc. | Benzamidine derivative |
| SE9804313D0 (sv) | 1998-12-14 | 1998-12-14 | Astra Ab | New compounds |
| CZ20012529A3 (cs) | 1999-01-13 | 2001-11-14 | Astrazeneca Ab | Nový amidinobenzylamidový derivát a jeho pouľití jako inhibitoru thrombinu |
| ATE281466T1 (de) * | 1999-04-09 | 2004-11-15 | Abbott Gmbh & Co Kg | Niedermolekulare inhibitoren von komplementproteasen |
| AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
| SE0001803D0 (sv) | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
| US6433186B1 (en) | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
| DE10049937A1 (de) * | 2000-10-06 | 2002-04-11 | Knoll Ag | Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten |
| AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
| US7129233B2 (en) | 2000-12-01 | 2006-10-31 | Astrazeneca Ab | Mandelic acid derivatives and their use as thrombin inhibitors |
| DE10064797A1 (de) * | 2000-12-22 | 2002-06-27 | Knoll Ag | Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon |
| DE10117730A1 (de) * | 2001-04-09 | 2002-10-10 | Basf Ag | Umsetzung von (Di)Aminen in Gegenwart einer Lysinoxidase und eines Reduktionsmittels |
| AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
| SE0201659D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
| SE0201661D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
| US6849084B2 (en) * | 2002-12-31 | 2005-02-01 | Intek Technology L.L.C. | Stent delivery system |
| US7781424B2 (en) * | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
| EP1736465A4 (en) * | 2004-03-31 | 2009-06-17 | Ajinomoto Kk | ANILINE DERIVATIVES |
| US7524354B2 (en) * | 2005-07-07 | 2009-04-28 | Research Foundation Of State University Of New York | Controlled synthesis of highly monodispersed gold nanoparticles |
| TW200827336A (en) * | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
| US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
| RS57870B1 (sr) | 2010-01-06 | 2018-12-31 | Dyax Corp | Proteini koji vezuju kalikrein plazme |
| KR102320178B1 (ko) * | 2011-01-06 | 2021-11-02 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 결합 단백질 |
| US20160017055A1 (en) | 2013-03-15 | 2016-01-21 | Dyax Corp. | Anti-plasma kallikrein antibodies |
| KR102424183B1 (ko) | 2014-01-21 | 2022-07-26 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 결합 단백질 및 유전성 혈관부종을 치료하는 데 있어서의 이의 용도 |
| KR102555955B1 (ko) | 2014-03-27 | 2023-07-18 | 다케다 파머수티컬 컴패니 리미티드 | 당뇨병성 황반 부종의 치료를 위한 조성물 및 방법 |
| EA201891388A1 (ru) | 2015-12-11 | 2018-11-30 | Дайэкс Корп. | Ингибиторы калликреина плазмы и их применение для лечения обострения наследственного ангионевротического отека |
| US12528880B2 (en) | 2020-01-13 | 2026-01-20 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU675981B2 (en) | 1992-12-02 | 1997-02-27 | Bristol-Myers Squibb Company | Guanidinyl-substituted heterocyclic thrombin inhibitors |
| SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
| IL112795A (en) | 1994-03-04 | 2001-01-28 | Astrazeneca Ab | Peptide derivatives as antithrombic agents their preparation and pharmaceutical compositions containing them |
| DE4421052A1 (de) | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
| MX9706069A (es) | 1995-02-17 | 1997-10-31 | Basf Ag | Nuevos inhibidores de la trombina. |
| DE19632773A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
-
1996
- 1996-08-14 DE DE19632772A patent/DE19632772A1/de not_active Withdrawn
-
1997
- 1997-07-29 DE DE59702414T patent/DE59702414D1/de not_active Expired - Fee Related
- 1997-07-29 US US09/242,126 patent/US6440937B1/en not_active Expired - Fee Related
- 1997-07-29 HU HU0001796A patent/HUP0001796A3/hu unknown
- 1997-07-29 BR BR9711134A patent/BR9711134A/pt not_active IP Right Cessation
- 1997-07-29 KR KR1019997001284A patent/KR20000030004A/ko not_active Withdrawn
- 1997-07-29 CN CN97198721A patent/CN1233256A/zh active Pending
- 1997-07-29 AU AU37715/97A patent/AU717692B2/en not_active Ceased
- 1997-07-29 EP EP97934552A patent/EP0918792B1/de not_active Expired - Lifetime
- 1997-07-29 IL IL12823197A patent/IL128231A0/xx unknown
- 1997-07-29 ES ES97934552T patent/ES2151741T3/es not_active Expired - Lifetime
- 1997-07-29 CZ CZ99311A patent/CZ31199A3/cs unknown
- 1997-07-29 AT AT97934552T patent/ATE196637T1/de not_active IP Right Cessation
- 1997-07-29 JP JP10509341A patent/JP2000517300A/ja active Pending
- 1997-07-29 WO PCT/EP1997/004105 patent/WO1998006740A1/de not_active Ceased
- 1997-07-29 CA CA002263344A patent/CA2263344A1/en not_active Abandoned
- 1997-08-08 TW TW086111384A patent/TW442471B/zh active
- 1997-08-13 ZA ZA977240A patent/ZA977240B/xx unknown
-
1999
- 1999-02-12 NO NO990667A patent/NO990667L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU717692B2 (en) | 2000-03-30 |
| ATE196637T1 (de) | 2000-10-15 |
| ES2151741T3 (es) | 2001-01-01 |
| IL128231A0 (en) | 1999-11-30 |
| ZA977240B (en) | 1999-02-15 |
| DE59702414D1 (de) | 2000-11-02 |
| DE19632772A1 (de) | 1998-02-19 |
| EP0918792A1 (de) | 1999-06-02 |
| HUP0001796A3 (en) | 2001-12-28 |
| CZ31199A3 (cs) | 1999-06-16 |
| NO990667D0 (no) | 1999-02-12 |
| HUP0001796A2 (hu) | 2000-11-28 |
| JP2000517300A (ja) | 2000-12-26 |
| WO1998006740A1 (de) | 1998-02-19 |
| CA2263344A1 (en) | 1998-02-19 |
| CN1233256A (zh) | 1999-10-27 |
| NO990667L (no) | 1999-04-12 |
| US6440937B1 (en) | 2002-08-27 |
| EP0918792B1 (de) | 2000-09-27 |
| KR20000030004A (ko) | 2000-05-25 |
| TW442471B (en) | 2001-06-23 |
| AU3771597A (en) | 1998-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9711134A (pt) | Composto e uso de um composto | |
| TR200800474T2 (tr) | Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem. | |
| MX9603050A (es) | Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas. | |
| BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
| AU6613896A (en) | Chemical compounds | |
| AU5554198A (en) | 3-thiocarbamoylpyrazole derivatives as pesticides | |
| RU94036004A (ru) | Промежуточные соединения для получения ароматических аминоспиртовых производных | |
| AU8599091A (en) | Antimicrobial agents as well as substituted 2-cyclohexan-1-y1-amine derivatives and their preparation | |
| ZA9710796B (en) | Oxyiminopregnanecarbolactones. | |
| TR200002380T2 (tr) | Yeni triazolo (4,5-d) pirimidin bileşikleri | |
| NO306116B1 (no) | Ny benzotiadiazinforbindelse og farmasöytiske sammensetninger | |
| IS4367A (is) | CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín | |
| AU1192397A (en) | Substituted thiazolines and their use for controlling animal pests | |
| ES2098338T3 (es) | Heteroarilmetilbencenos. | |
| AU3774097A (en) | Intermediates for the preparation of 2-imidazoline-5-ones | |
| PT1104419E (pt) | Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao | |
| AU4944097A (en) | Sulfonyl benzazolones | |
| DE69711506D1 (de) | Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung | |
| MX9804955A (es) | Antibioticos hidrosolubles. | |
| MY133139A (en) | N-substituted azabicycloheptane derivatives, their preparation and use | |
| ATE150023T1 (de) | Neue triazolopyrimidone, ihre herstellung und verwendung | |
| GR1001405B (el) | Ενώσεις 2-πιπεραζινόνης και η παραγωγή και η χρησιμοποίηση αυτών. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: ABBOTT GMBH AND CO. KG (DE) Free format text: TRANSFERIDO DE: BASF AKTIENGESELLSCHAFT |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A , 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1838 DE 28/03/2006. |